Mutsuo Taiji Selected Research

salicylhydroxamic acid (SHAM)

1/2008

Chronic administration of SMP-534 ameliorates renal dysfunction in 5/6 nephrectomized rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mutsuo Taiji Research Topics

Disease

5	Fibrosis (Cirrhosis) 06/2009 - 11/2005
4	Body Weight (Weight, Body) 04/2011 - 02/2005
3	Cognitive Dysfunction 03/2014 - 06/2013
3	Schizophrenia (Dementia Praecox) 07/2013 - 05/2013
3	Type 2 Diabetes Mellitus (MODY) 10/2009 - 04/2006
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2007 - 01/2006
3	Acute Kidney Injury (Acute Renal Failure) 01/2004 - 02/2002
2	Hyperglycemia 06/2008 - 02/2003
2	Renal Insufficiency (Renal Failure) 01/2008 - 04/2006
2	Nephritis 04/2006 - 11/2005
2	Hyperplasia 04/2002 - 01/2002
1	Memory Disorders (Memory Loss) 05/2013
1	Hepatocellular Carcinoma (Hepatoma) 10/2009
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2009
1	Hypertension (High Blood Pressure) 01/2008
1	Glomerulonephritis 11/2005
1	Insulin Resistance 02/2003
1	Rhabdomyolysis 08/2002
1	Necrosis 08/2002
1	Ischemia 08/2002
1	Hyperinsulinism (Hyperinsulinemia) 05/2002
1	Nervous System Diseases (Neurological Disorders) 05/2002
1	Pathologic Constriction (Stenosis) 01/2002

Drug/Important Bio-Agent (IBA)

6	SMP-534IBA 06/2009 - 11/2005
5	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2004 - 01/2002
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2008 - 05/2002
3	Lurasidone Hydrochloride FDA Link 03/2014 - 05/2013
3	Blood Glucose (Blood Sugar)IBA 04/2011 - 05/2002
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2006 - 11/2005
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2013 - 05/2013
2	Antipsychotic Agents (Antipsychotics)IBA 06/2013 - 05/2013
2	Metformin (Glucophage)FDA LinkGeneric 10/2009 - 08/2008
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2009 - 05/2002
2	Glucose (Dextrose)FDA LinkGeneric 10/2009 - 02/2005
2	Losartan (Cozaar)FDA LinkGeneric 01/2007 - 01/2006
2	Insulin (Novolin)FDA Link 04/2006 - 02/2003
2	AlbuminsIBA 04/2006 - 01/2006
2	Glycerol (Glycerine)FDA LinkGeneric 01/2004 - 08/2002
1	Clozapine (Clozaril)FDA LinkGeneric 03/2014
1	Ketamine FDA LinkGeneric 07/2013
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 07/2013
1	SK&F 81297IBA 07/2013
1	Serotonin (5 Hydroxytryptamine)IBA 06/2013
1	Dopamine (Intropin)FDA LinkGeneric 06/2013
1	SB-656104-AIBA 05/2013
1	serotonin 7 receptorIBA 05/2013
1	N-Methylaspartate (NMDA)IBA 05/2013
1	Dizocilpine Maleate (Dizocilpine)IBA 05/2013
1	LipidsIBA 04/2011
1	SaltsIBA 04/2011
1	SodiumIBA 04/2011
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 10/2009
1	Adenosine Triphosphate (ATP)IBA 10/2009
1	AMP-Activated Protein KinasesIBA 10/2009
1	EnzymesIBA 10/2009
1	Messenger RNA (mRNA)IBA 10/2009
1	RotenoneIBA 10/2009
1	indium-bleomycinIBA 06/2009
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2009
1	BiguanidesIBA 08/2008
1	salicylhydroxamic acid (SHAM)IBA 01/2008
1	Antihypertensive Agents (Antihypertensives)IBA 01/2007
1	Antifibrotic AgentsIBA 04/2006
1	benzamideIBA 04/2006
1	Angiotensin IIIBA 01/2006
1	anti-Thy antibodyIBA 11/2005
1	Hydroxyproline (4 Hydroxyproline)IBA 11/2005
1	Nerve Growth Factors (Neurotrophins)IBA 02/2003
1	2-(9-oxo)nonanoyl glycerolIBA 08/2002
1	Polytetrafluoroethylene (Teflon)FDA Link 04/2002

Therapy/Procedure

1	Therapeutics 01/2006
1	Oral Administration 11/2005
1	Blood Vessel Prosthesis 04/2002
1	Surgical Instruments (Clip) 01/2002